Forget the mega-caps — Friday’s most explosive moves happened almost entirely below $4 a share. A clinical-stage biotech nearly doubled on a Phase 3 enrollment milestone, a golf-simulator company pivoted into tokenized securities, and not one but two companies announced reverse splits taking effect at Monday’s open. If you’re looking for where the real volatility lives heading into the new week, here are the 10 top stocks under $4 to watch tomorrow — all sub-$4, all moving on real news, and none of them the usual mega-cap suspects.
1. Biodexa Pharmaceuticals (BDRX) | Closed at $1.30, Up 96.94% on a Phase 3 Milestone
A Clinical Milestone Meets a Cash Warning in the Same Breath
Biodexa Pharmaceuticals nearly doubled Friday after reporting real clinical progress — but the company’s own interim results carried an uncomfortable financing caveat.
Full Data & Snapshot:
| Metric | Value |
|---|---|
| Last Close | $1.30 |
| Daily Move | +96.94% |
| Intraday High | $1.55 |
| Volume | 142,428,544 shares |
| Market Cap | ~$1.34M |
| H1 2026 Net Loss | £1.84M |
| Operating Cash Outflow | £4.61M |
Catalyst & News: Biodexa reported that Phase 3 enrollment for eRapa in familial adenomatous polyposis (FAP) has now exceeded the half-way mark — a key clinical de-risking event for the company’s lead program. In the same interim results filing, however, management disclosed no revenue for the period and warned that additional financing will be needed in the fourth quarter. Outstanding warrants carry a $2.85 strike price, well above Friday’s close, meaning that near-term source of capital isn’t currently accessible to the company.
Technicals: Volume of over 142 million shares is staggering relative to the company’s tiny reported share count, reflecting extremely active short-term trading rather than a stable re-rating. Resistance sits at $1.55, Friday’s intraday high, with major resistance at the $2.85 warrant strike price — a level that would meaningfully improve the company’s financing options if reclaimed. Support sits at $0.66, Thursday’s close before the move.
Bull Case: Crossing the enrollment halfway point in a registrational Phase 3 trial is genuine derisking for a clinical-stage biotech, and continued positive trial progress could attract partnership or licensing interest that solves the financing question without further dilutive equity raises.
Bear Case: The company explicitly needs more cash this quarter, and at current prices, any financing is likely to be highly dilutive to existing shareholders — the clinical win and the balance-sheet stress are pulling in opposite directions.
Forecast: Watch closely for a financing announcement in the coming weeks — the terms of that raise, more than the clinical news itself, will likely determine whether Friday’s gains hold.
2. Future FinTech Group (FTFT) | Closed at $2.88, Up 40.49% on Pure Speculation
A Post-Reverse-Split Stock Becomes a Trading Vehicle
Future FinTech Group surged again Friday with no fresh operational news — just speculative momentum trading in a stock still adjusting to a recent share-count reduction.
Full Data & Snapshot:
| Metric | Value |
|---|---|
| Last Close | $2.88 |
| Daily Move | +40.49% |
| Volume | 53,280,484 shares |
| Market Cap | ~$23.22M |
| 12-Month Performance | −98.8% |
| FY2025 Revenue | $3.83M |
Catalyst & News: Analysts covering the move flagged the clearest explanation as speculative trading rather than any new corporate announcement, compounded by the fact that FTFT completed another 1-for-4 reverse stock split in late August aimed at meeting Nasdaq’s minimum bid price requirement. The company has now executed multiple reverse splits in 2026, a pattern that tends to make already-thin stocks even more volatile once the reduced share count starts trading.
Technicals: Friday’s volume of over 53 million shares dwarfs the company’s typical turnover, a hallmark of momentum-driven, headline-free trading. Resistance sits at $3.50–$4.00, levels the stock hasn’t approached since its most recent reverse split. Support sits at $2.05, Thursday’s close.
Bull Case: A stock down 98.8% over the trailing year has very little room left to fall on a percentage basis, and any actual operational news — rather than pure speculation — could sustain a move that’s currently built on thin air.
Bear Case: With no identifiable catalyst behind Friday’s pop, this is close to a textbook case of unsustainable momentum trading in a serially-diluted micro-cap that has needed multiple reverse splits just to stay listed.
Forecast: Absent a genuine business update, expect this move to fade quickly — speculative pops without news in heavily reverse-split stocks rarely hold.
3. Nocera (NCRA) | Closed at $2.23, Up 19.89% on Its AI Pivot Story
From Fish Farms to AI Data Centers — A Complete Corporate Transformation
Nocera, once a pure aquaculture consulting business, continued its rally as its transformation into a diversified “Nocera Holdings” technology platform gains traction.
Full Data & Snapshot:
| Metric | Value |
|---|---|
| Last Close | $2.23 |
| Daily Move | +19.89% |
| Volume | 610,780 shares |
| Market Cap | ~$4.76M |
| Stockholders’ Equity | $5.4M (more than 2x Nasdaq minimum) |
Catalyst & News: Nocera has been executing a rapid strategic pivot, forming a 50/50 joint venture with INERGX Energy Optimisation targeting a $250 million valuation to consolidate the energy supply chain serving AI data centers, defense, and heavy industry. The company also recently cleared every open Nasdaq listing matter, regained full compliance, closed three binding transactions in sixty days, and separately disclosed plans to allocate capital toward Bitcoin for its corporate treasury — an increasingly common move among small-cap companies seeking to diversify balance-sheet assets.
Technicals: With average volume typically much lower, Friday’s turnover suggests building investor interest in the pivot story. Resistance sits at $2.50–$2.75, a level from recent weeks. Support sits at $1.86, Thursday’s close.
Bull Case: A company that has already cleared its Nasdaq compliance issues, holds equity well above the required minimum, and is stacking binding deals in the hot AI-infrastructure and energy space offers real optionality if even one of these ventures scales meaningfully.
Bear Case: Serial pivots — from aquaculture to AI to crypto treasury to energy infrastructure in the span of months — can be a red flag as much as an opportunity, and the company cautions in its own filings that there’s no assurance planned products or markets will be realized.
Forecast: Watch for concrete progress updates on the INERGX joint venture specifically — a scaled deal there would be the clearest signal this pivot has real substance behind it.
4. TruGolf Holdings (TRUG) | Closed at $0.653, Up 76.14% on a Tokenization Deal
An Indoor Golf Company Bets Its Future on Blockchain Securities
TruGolf, historically a golf-simulator and gaming-software company, rocketed higher on fresh developments tied to its recently announced pivot into tokenized securities infrastructure.
Full Data & Snapshot:
| Metric | Value |
|---|---|
| Last Close | $0.653 |
| Daily Move | +76.14% |
| Volume | 434,796,551 shares |
| Market Cap | ~$1.26M |
| 12-Month Performance | −98.9% |
Catalyst & News: TruGolf’s newly acquired subsidiary Polymath Research announced a partnership with High Ridge Trust to advance institutional infrastructure for tokenized securities — the latest development following TruGolf’s August announcement that it would acquire Polymath and bring “a tokenization innovator to the public markets on Nasdaq.” The company has since revised the preferred share structure tied to that acquisition and tied it to a $140 million new preferred stock issuance. Separately, the stock faces an active securities fraud class action, with law firm Bronstein, Gewirtz & Grossman continuing to urge investors to act.
Technicals: Volume of over 434 million shares is extraordinary even by penny-stock standards, reflecting a stock in the midst of a dramatic identity shift from golf technology to fintech infrastructure. Resistance sits at $0.75–$0.80, levels from earlier in the week. Support sits at $0.37, Thursday’s close.
Bull Case: Pivoting a legacy hardware business into the fast-growing tokenized real-world-asset space via the Polymath acquisition gives TruGolf exposure to one of 2026’s hottest fintech narratives, and the partnership with an established trust company adds a layer of institutional credibility.
Bear Case: The stock is down nearly 99% over the trailing year, faces active securities fraud litigation, and a $140 million preferred stock structure layered onto a company with a roughly $1 million common equity market cap raises serious questions about eventual dilution to common shareholders.
Forecast: This is a binary transformation story — either the Polymath tokenization pivot delivers real revenue and validates the new preferred structure, or legacy shareholders face substantial dilution with little to show for it.
5. Stewards Inc. (SWRD) | Closed at $2.96, Up 32.74% on a Fresh Nasdaq Uplisting
From the OTC Markets to Nasdaq in a Single Trading Session
Stewards Inc., a diversified financial platform spanning private credit and real assets, extended its gains just one session after officially graduating from the OTC markets to the Nasdaq Capital Market.
Full Data & Snapshot:
| Metric | Value |
|---|---|
| Last Close | $2.96 |
| Daily Move | +32.74% |
| Volume | 27,753,825 shares |
| Market Cap | ~$625.00M |
| Uplisting Date | September 10, 2026 |
| Cumulative Private Credit Originated | $153M+ since 2020 |
Catalyst & News: Stewards began trading on the Nasdaq Capital Market on September 10 after receiving approval to uplist directly from the OTCID Market, with no concurrent public offering or new share issuance involved in the move. The company describes itself as a diversified financial platform spanning private credit, income-producing real assets, and technology-enabled financial infrastructure, and highlights that its private credit business has originated more than $153 million in cumulative funding across over 10,000 small and midsized businesses since 2020.
Technicals: As a newly uplisted stock, SWRD lacks extended historical support and resistance levels, but Friday’s heavy volume relative to its pre-uplisting OTC turnover suggests strong initial institutional interest. Resistance sits at $3.25–$3.50, levels touched briefly during the first two sessions of Nasdaq trading. Support sits at $2.23, Thursday’s close.
Bull Case: A direct uplisting without dilutive new share issuance signals the company met Nasdaq’s listing standards on its own merits, and access to a broader base of institutional and index-fund investors following a Nasdaq listing often provides a durable valuation tailwind for previously OTC-traded names.
Bear Case: With just two trading days of Nasdaq history, there’s limited data to judge whether this is sustainable institutional accumulation or a short-lived uplisting pop that fades once initial curiosity buying subsides.
Forecast: The first full week of Nasdaq trading will be the real test — a stock that holds its gains and builds a stable trading range above $2.50 would suggest genuine institutional interest rather than a one-time listing bounce.
6. Advasa Holdings (ADBT) | Closed at $0.232, Down 24.82% in Extreme Volatility
A Crypto-Payments Fintech’s Wild Ride Continues
Advasa Holdings, a Japan-based fintech company that recently expanded into crypto payments, extended a punishing decline that has seen shares lose more than 90% of their value in just weeks.
Full Data & Snapshot:
| Metric | Value |
|---|---|
| Last Close | $0.232 |
| Daily Move | −24.82% |
| Volume | 20,776,761 shares |
| Market Cap | ~$113.15M |
| 52-Week Range | $0.26 – $13.20 |
| Direct Listing Date | ~August 18, 2026 |
Catalyst & News: Advasa Holdings, which operates the FUKUPE Earned Wage Access platform in Japan, recently announced that its ADVASA Visa card now supports USDC stablecoin payments alongside fiat currency, alongside plans to explore real-world-asset (RWA) tokenization opportunities. Despite the forward-looking crypto pivot, the stock has cratered since its August direct listing on Nasdaq, falling more than 93% in a single recent week according to trading data, as early enthusiasm around the newly listed fintech gave way to intense volatility and profit-taking.
Technicals: Volume remains extraordinarily elevated relative to the company’s size, a pattern consistent with a newly listed stock still searching for a stable trading range. Resistance sits at $0.31–$0.37, levels from earlier in the week. Support sits at $0.26, near the stock’s 52-week low.
Bull Case: The USDC payment integration and RWA expansion plans position Advasa at the intersection of two hot fintech themes, and a stock that has already fallen this dramatically from its $13.20 high offers asymmetric upside if the crypto pivot gains real commercial traction.
Bear Case: A more than 90% decline in a matter of weeks following a direct listing is an extreme red flag suggesting the original listing valuation was disconnected from underlying fundamentals, and newly public micro-caps in this situation frequently continue grinding lower before finding a genuine floor.
Forecast: This remains an exceptionally high-risk, high-volatility situation — watch for the stock to either stabilize above $0.26 support or break to fresh lows, with little middle ground likely given the trading pattern so far.
7. GlucoTrack (GCTK) | Closed at $2.55, Down 21.05% Post-Reverse Split
A Diabetes-Tech Company’s Biotech Subsidiary Advances While the Stock Struggles
GlucoTrack, best known for its implantable continuous glucose monitor technology, fell sharply as it continues adjusting to a recent reverse split even as its biotech subsidiary hits a manufacturing milestone.
Full Data & Snapshot:
| Metric | Value |
|---|---|
| Last Close | $2.55 |
| Daily Move | −21.05% |
| Volume | 744,172 shares |
| Market Cap | ~$1.06M |
| Split Ratio | 1-for-15, effective Aug. 31, 2026 |
Catalyst & News: GlucoTrack’s subsidiary Lokahi Therapeutics initiated its Good Manufacturing Practice (GMP) manufacturing campaign for LT-100, the subsidiary’s lead development candidate — a meaningful operational milestone. However, the parent stock continues to feel pressure following its August 31 reverse split, executed to support Nasdaq listing compliance, with the Nasdaq Hearings Panel having granted continued listing subject to certain conditions.
Technicals: Shares remain volatile as the market digests the post-split share count alongside the Lokahi subsidiary news. Resistance sits at $3.50–$4.00, levels touched shortly after the reverse split took effect. Support sits at $2.15, a level from earlier this week.
Bull Case: The Lokahi Therapeutics GMP manufacturing milestone for LT-100 represents genuine biotech pipeline progress that’s somewhat decoupled from the core glucose-monitoring business, giving the company two distinct paths to a positive catalyst.
Bear Case: A company that just executed a reverse split for listing compliance and continues operating under Nasdaq Hearings Panel conditions faces real going-concern-adjacent risk, and the combination of dual business lines (diabetes devices and biotech) can dilute investor focus and capital allocation.
Forecast: Watch for updates on the Nasdaq Hearings Panel conditions — continued compliance progress would remove a significant overhang, while any setback there could pressure shares further regardless of the Lokahi subsidiary’s progress.
8. Ocean Power Technologies (OPTT) | Closed at $0.107, Down 33.44% Into Monday’s Split
A Maritime Tech Company’s Reverse Split Takes Effect at Monday’s Open
Ocean Power Technologies tumbled hard Friday as markets priced in a dramatic reverse split set to take effect at the very next trading session.
Full Data & Snapshot:
| Metric | Value |
|---|---|
| Last Close | $0.107 |
| Daily Move | −33.44% |
| Volume | 63,547,297 shares |
| Market Cap | ~$28.48M |
| 52-Week Range | $0.13 – $0.72 |
| Split Ratio | 1-for-30, effective Sept. 14, 2026 |
| 12-Month Performance | −71.9% |
Catalyst & News: Ocean Power Technologies’ previously announced 1-for-30 reverse stock split takes effect at Monday’s market open, consolidating every 30 shares into one. The move follows a going-concern qualification disclosed in the company’s most recent 10-K and a board-launched strategic alternatives review announced in August. On the operational side, the company has been demonstrating its WAM-V unmanned surface vessel platform alongside the U.S. Army’s Engineer Research and Development Center in a week-long coastal testing program — a potential defense-contract pathway that stands somewhat apart from the capital-structure concerns.
Technicals: With Monday marking the first split-adjusted session, traditional support and resistance levels reset entirely. Watch the opening print closely — a stable open near the theoretical split-adjusted price (roughly $3.21 based on Friday’s $0.107 close) would suggest orderly trading, while a sharp gap in either direction would signal continued volatility.
Bull Case: Active participation in a U.S. Army coastal-testing demonstration for its WAM-V platform gives OPTT a credible defense-sector pathway, and a successful reverse split combined with the ongoing strategic alternatives review could result in a cleaner capital structure or even a sale of assets that unlocks value.
Bear Case: A going-concern warning is one of the most serious red flags a company can disclose, and reverse splits executed under this kind of financial distress have a poor track record of actually resolving the underlying cash shortfall.
Forecast: Monday’s split-adjusted open is the single most important session for this name all month — watch closely for how the stock behaves in the first hour of trading as the market establishes a new baseline.
9. NextNRG (NXXT) | Closed at $0.158, Down 18.32% Ahead of Monday’s Split
A Second Reverse Split Takes Effect at the Same Open as Ocean Power
NextNRG joins Ocean Power Technologies as the second stock on this list with a reverse split taking effect at Monday’s market open — a notable coincidence highlighting broader stress across small-cap Nasdaq names.
Full Data & Snapshot:
| Metric | Value |
|---|---|
| Last Close | $0.158 |
| Daily Move | −18.32% |
| Volume | 3,480,527 shares |
| Market Cap | ~$26.55M |
| 52-Week Range | $0.151 – $2.88 |
| Split Ratio | 1-for-10, effective Sept. 14, 2026 |
Catalyst & News: NextNRG’s 1-for-10 reverse stock split, announced Thursday, takes effect Monday, consolidating roughly 168.4 million outstanding shares into approximately 16.8 million. The AI-driven energy infrastructure and mobile fuel-delivery company has otherwise shown genuine revenue momentum, including a recently announced 25-year microgrid contract win in Florida, and notably, the company’s CEO has been a recent open-market buyer of shares even as the stock touched fresh 52-week lows.
Technicals: Shares touched a fresh 52-week low of $0.151 intraday before Friday’s close. Watch Monday’s split-adjusted open closely — the theoretical split-adjusted price based on Friday’s close works out to roughly $1.58.
Bull Case: Six consecutive months of double-digit year-over-year revenue growth, a long-duration microgrid contract win, and a CEO buying shares in the open market ahead of the split all suggest management sees more value in the business than the stock price currently reflects.
Bear Case: Rising short interest heading into the split and a business still generating meaningful net losses suggest the reverse split addresses the symptom of a depressed share price without necessarily resolving underlying cash-burn challenges.
Forecast: Like Ocean Power, Monday’s opening session is critical — a stable post-split open would be a modestly encouraging sign, while continued heavy selling would suggest structural issues remain regardless of the new share count.
10. America’s Car-Mart (CRMT) | Closed at $1.90, Up 19.50% on a Stunning Earnings Beat
A Company Facing Wind-Down Rumors Just Delivered a Massive Profit Surprise
America’s Car-Mart rounds out this list after delivering one of the most dramatic earnings surprises of the week — from a company that Bloomberg reported just two months ago might be exploring a complete wind-down.
Full Data & Snapshot:
| Metric | Value |
|---|---|
| Last Close | $1.90 |
| Daily Move | +19.50% |
| Volume | 2,981,313 shares |
| Market Cap | ~$15.84M |
| 52-Week Range | $1.37 – $35.50 |
| Q1 FY2027 Adjusted EPS | $1.64 (vs. −$0.77 consensus) |
Catalyst & News: America’s Car-Mart reported first-quarter fiscal 2027 adjusted EPS of $1.64, dramatically beating the consensus estimate of a $0.77 per-share loss. The beat lands just days after the company secured a short-term extension of a credit waiver amid an ongoing strategic review, following a July Bloomberg report that the used-vehicle retailer was exploring asset sales and could potentially wind down entirely. The stock remains subject to an active securities class-action investigation led by Rosen Law Firm.
Technicals: Shares are down more than 94% from their 52-week high of $35.50, underscoring the severity of the distress that led to this point, but Friday’s volume of nearly 3 million shares — roughly five times the daily average — shows real conviction behind the move. Resistance sits at $2.14, Friday’s intraday high. Support sits at $1.54, Friday’s intraday low, with the 52-week low of $1.37 as a critical floor below that.
Bull Case: A profit beat of this scale combined with a successfully extended lender waiver suggests the underlying business may be more stable than the wind-down headlines implied, and the tiny market cap means continued good news could produce further outsized percentage gains.
Bear Case: This is still a company that was reportedly exploring a full wind-down within the past two months and faces ongoing securities-fraud litigation risk — one strong quarter doesn’t resolve the credit and capital-structure issues that created this situation.
Forecast: A confirmed break above $2.14 with continued lender cooperation would be the clearest sign of stabilization; any negative update on the waiver situation could quickly erase this week’s gains.
At a Glance: Stocks Under $4 to Watch Tomorrow
| Rank | Stock (Ticker) | Last Close | % Change | Catalyst |
|---|---|---|---|---|
| 1 | Biodexa Pharmaceuticals (BDRX) | $1.30 | +96.94% | Phase 3 enrollment milestone |
| 2 | Future FinTech Group (FTFT) | $2.88 | +40.49% | Speculative post-split trading |
| 3 | Nocera (NCRA) | $2.23 | +19.89% | AI/energy infrastructure pivot |
| 4 | TruGolf Holdings (TRUG) | $0.653 | +76.14% | Tokenized securities partnership |
| 5 | Stewards Inc. (SWRD) | $2.96 | +32.74% | Fresh Nasdaq uplisting |
| 6 | Advasa Holdings (ADBT) | $0.232 | −24.82% | Crypto payments pivot, extreme volatility |
| 7 | GlucoTrack (GCTK) | $2.55 | −21.05% | Post-reverse-split, biotech milestone |
| 8 | Ocean Power Technologies (OPTT) | $0.107 | −33.44% | Reverse split effective Monday |
| 9 | NextNRG (NXXT) | $0.158 | −18.32% | Reverse split effective Monday |
| 10 | America’s Car-Mart (CRMT) | $1.90 | +19.50% | Massive earnings beat |
Follow TNN for daily stock market news and financial news today.
Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. Stocks trading under $4 — often referred to as penny stocks — carry substantially elevated risk, including low liquidity, high volatility, and heightened potential for total capital loss. Stock prices, percentage moves, technical levels, and market data cited reflect figures available at the time of publication and are subject to change as trading continues. Always complete independent due diligence prior to executing equity trades.
About The Author
